Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,525 | 225,525 | 168,669 | 106,801 | 44,588 |
| Depreciation Amortization | 6,907 | 24,097 | 17,271 | 11,137 | 5,480 |
| Income taxes - deferred | 6,299 | 29,380 | 22,920 | 14,187 | 12,946 |
| Accounts receivable | 8,763 | -12,059 | -6,925 | 4,767 | 3,014 |
| Accounts payable and accrued liabilities | -4,762 | 2,629 | -8,147 | -10,128 | -4,458 |
| Other Working Capital | -26,781 | -17,386 | -23,648 | -51,367 | -20,035 |
| Other Operating Activity | 91,458 | 22,392 | 17,963 | 33,571 | -9,776 |
| Operating Cash Flow | $55,359 | $274,578 | $188,103 | $108,968 | $31,759 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -139,021 | -159,556 | -149,422 | -74,361 | 77,747 |
| PPE Investments | -7,170 | -53,383 | -27,274 | -19,552 | -10,044 |
| Net Acquisitions | -82,821 | -52,183 | -52,183 | -52,183 | -51,947 |
| Purchase Of Investment | -3,866 | -26,104 | -26,104 | -3,100 | -2,000 |
| Sale Of Investment | 123,823 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 67,882 | 67,882 | 67,882 | 0 |
| Investing Cash Flow | $-109,055 | $-223,344 | $-187,101 | $-81,314 | $13,756 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,120 | 14,554 | 9,054 | 7,533 | 1,010 |
| Common Stock Repurchased | 0 | -11,310 | -11,310 | -11,310 | -11,310 |
| Other Financing Activity | -9,590 | -11,311 | -11,176 | -10,934 | -9,857 |
| Financing Cash Flow | $-7,470 | $-8,067 | $-13,432 | $-14,711 | $-20,157 |
| Exchange Rate Effect | 3,910 | -2,798 | 1,107 | -3,043 | -2,872 |
| Beginning Cash Position | 232,710 | 192,341 | 192,341 | 192,341 | 192,341 |
| End Cash Position | 175,454 | 232,710 | 181,018 | 202,241 | 214,827 |
| Net Cash Flow | $-57,256 | $40,369 | $-11,323 | $9,900 | $22,486 |
| Free Cash Flow | |||||
| Operating Cash Flow | 55,359 | 274,578 | 188,103 | 108,968 | 31,759 |
| Capital Expenditure | -7,170 | -53,383 | -27,274 | -19,552 | -10,044 |
| Free Cash Flow | 48,189 | 221,195 | 160,829 | 89,416 | 21,715 |